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Abstract 
In the presence of Ca 2 ÷ bound to calmodulin, Ca 2 +/calmodulin-dependent pro ein kinase II (CaMK II) exhibits an intramolecular 
autophosphorylation and modulates many cell functions. In this study, the role of CaMK II in pepsinogen secretion was investigated in 
cultured guinea pig chief cells by using a specific CaMK II inhibitor, 1-[N,O-Bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl- 
piperazine (KN-62), and an antibody for the Thr-286-autophospholylated  subunit of CaMK II which specifically recognized the 
autophosphorylated form of CaMK II. KN-62 inhibited the pepsinogen secretion stimulated by carbamylcholine chloride, cholecystokinin 
octapeptide, and ionomycin in a dose-dependent manner without affecting intracellular Ca 2+ concentrations, but had no effect on the 
secretion by 12-O-tetradecanoyl phorbol-13-acetate (TPA) and forskolin. Heavy staining with the antibody for autophosphorylated CaMK 
II was observed in the cytoplasm of chief cells treated with carbamylcholine chloride or ionomycin, but only light staining was seen in 
cells treated with TPA or forskolin. Thus, CaMK II and its autophosphorylation may be a critical step in the intracellular pathway by 
which Ca 2+ causes pepsinogen secretion from guinea pig chief cells. 
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1. Introduction 
Pepsinogen secretion is mediated by cAMP and 
Ca2+/calmodulin-dependent signal transduction pathways 
in chief cells [1,2]. Both pathways require activation of 
specific protein kinases. C~LVIK II is a member of a family 
of Ca2+/calmodulin-regulated protein kinases that in- 
cludes myosin light-chain kinase, phosphorylase kinase, 
and Cae+/calmodulin-dependent pro ein kinases I and III 
[3-5]. Unlike the other kinases of this family, CaMK II 
can phosphorylate many proteins and modulate cellular 
Abbreviations: Carbachol, carbamylcholine chloride; CaMK II, 
Ca2+/calmodulin-dependent prol:ein kinase II; CCK-8, cholecystokinin 
octapeptide; Hepes, N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic 
acid; [Ca 2+ ]i, intracellular free Ca 2+ concentration; KN-62, 1-[N,O- 
Bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine; KN- 
04, N-[1-[ N-methyl-p-(5-isoquinolinesulfonyl)benzyl-2-(4-phenylpipera- 
zine)ethyl]-5-isoquinolinesulfonatnide; TPA, 12-O-tetradecanoyl phorbol- 
13-acetate. 
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events such as neurotransmitter exocytosis, catecholamine 
biosynthesis, cytoskeletal interactions, and glycogen 
metabolism [5,6]. The participation of this kinase in acid 
secretion was recently demonstrated in rabbit parietal cells 
[7-9] with the use of a specific inhibitor, KN-62 [10]. In 
addition, myosin light-chain kinase, a member of the same 
family as CaMK II, is involved in pepsinogen secretion 
[11]. These reports suggest hat CaMK II may play a role 
in the secretion of pepsinogen. 
In the presence of Ca2+/calmodulin, CaMK II exhibits 
an intramolecular autophosphorylation that alters this en- 
zyme to a partially Ca2+/calmodulin-independent form 
[12-14]. The extent of CaMK II autophosphorylation can 
be assessed by an immunohistochemical technique with a 
specific antibody for the Thr-286-autophosphorylated a 
subunit of CaMK II [15]. 
In this study, the role of CaMK II in pepsinogen 
secretion was examined in cultured guinea pig chief cells 
by using both KN-62 and the antibody that recognizes 
autophosphorylation of this kinase. 
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2. Materials and methods 
2.1. Monolayer culture of  guinea pig chief cells 
Monolayer cultures of guinea pig chief cells were pre- 
pared as reported [11]. A male Hartley guinea pig (body 
weight 200-300 g) was anesthetized with ether, and the 
stomach was removed. After stripping the mucosal ayer, 
the gastric mucosa was cut into small pieces (< 2 mm2), 
incubated and shaken (160 osci l lat ions/min) for 60 min at 
37°C in Ca2+-free medium [containing 24.5 mM Hepes 
(pH 7.4), 98 mM NaC1, 6 mM KC1, 2.5 mM sodium 
phosphate, 5 mM sodium pyruvate, 5 mM sodium fu- 
marate, 5 mM sodium glutamate, 11.5 mM glucose, 2 mM 
glutamine, 0.1% (w/v )  bovine serum albumin (fraction V; 
Seikagaku Kogyo, Tokyo, Japan), 0.1% (w/v )  soybean 
trypsin inhibitor (Sigma, St. Louis, MO), 1% (v /v )  essen- 
tial amino acid solution (Whittaker Bioproducts, Walk- 
ersville, MD), and 1% (v /v )  essential vitamin mixture 
(Whittaker)] with 0.1% (w/v )  collagenase (Wako Pure 
Chemical Industries, Osaka, Japan). After passage through 
200-/zm nylon mesh, the dispersed cells were incubated 
and shaken for 30 min at 37 ° C in the same medium with 2 
mM EGTA (Dojin Laboratories, Kumamoto, Japan). After 
passage through 80-/zm nylon mesh, the cell suspension 
was centrifuged in Percoll solution (density, 1.129 g /ml )  
(Pharmacia LKB, Uppsala, Sweden) at 30 000 × g for 20 
min. The chief cell-enriched fraction was collected by 
aspiration and suspended in culture medium comprising a
1:1 mixture of Ham's F-12 medium and DMEM (Gibco, 
Grand Island, NY) supplemented with 10% (v /v )  fetal 
bovine serum (Whittaker), gentamicin (100 /zg /ml )  
(Gibco), insulin (8 txg/ml)  (Wako), and hydrocortisone (1
/xg/ml)  (Wako). The chief cell suspension was then 
planted into 12-well plates (2 • 10 6 cel ls /wel l )  coated with 
collagen type ! (Sumitomo Bakelite, Akita, Japan) and 
cultured under 5% CO 2 in air at 37°C for 70 h (CO 2 
incubator 6300; Napco Scientific, Tualatin, OR). 
2.2. Pepsinogen secretion studies 
tion of drugs to the culture medium and incubated under 
5% CO 2 in air at 37°C for the appropriate time. Samples 
of culture medium were subsequently removed, and then 
pepsinogen secreted into the medium was measured by an 
enzyme immunoassay specific for guinea pig pepsinogen 
as previously described [11]. At the end of the experiment, 
the chief cells were removed from the plate by exposure to 
0.04% (v /v )  trypsin with 0.02% (w/v )  EGTA, and 
counted. Pepsinogen secretion was expressed as nanograms 
of pepsinogen per 5 • l0 s chief cells, and cell viability was 
determined by exclusion of trypan blue. 
In preliminary dose-response studies, appropriate doses 
of carbachol (Sigma) and CCK-8 (sulfated form; Peptide 
Institute, Osaka, Japan), both of which stimulate the Ca 2 ÷ 
second messenger pathway; the Ca 2÷ ionophore iono- 
mycin (Calbiochem, La Jolla, CA), TPA (Sigma), which 
directly stimulates protein kinase C; and forskolin (Wako) 
which stimulates the cAMP second messenger pathway, 
were determined. Carbachol (n = 6), CCK-8 (n = 6), iono- 
mycin (n = 6), TPA (n = 6), and forskolin (n = 6) signifi- 
cantly increased the secretion of pepsinogen at concentra- 
tions of 10 -5 M to 10 -3 M, 10 -6 M to 2 .10  -5 M, 10 -6 
M to 2- 10 -5 M, 10 -8 M to 10 -7 M, and 10 -5 M to 
10 -4 M, respectively (Table 1). Concentrations that sub- 
maximally stimulate pepsinogen secretion (10 -4 M for 
carbachol, 10 -5 M for CCK-8, 10 -6 M for ionomycin, 
10 -8 M for TPA, and 10 -5 M for forskolin) were used in 
the following studies. Time course studies were performed 
to confirm the effects of these doses and to determine the 
appropriate incubation times. Because significant and sub- 
maximal increases in pepsinogen secretion were observed 
for all drugs 30 min after stimulation (Table 2), cells were 
subsequently incubated with each secretagogue for 30 min. 
The effects of CaMK II on pepsinogen secretion stimu- 
lated by the secretagogues were determined by using KN-62 
(Seikagaku Kogyo) and KN-04 (Seikagaku Kogyo), an 
inactive analog of KN-62 [16]. 
2.3. Determination of  [Ca 2 + ]i 
The cell monolayers were washed three times with 
culture medium to remove floating cells before the addi- 
For determination of [Ca 2÷ ]i, chief cells were cultured 
for 48 h on a collagen type I (Koken, Tokyo, Japan)-coated 
Table 1 
Dose-response r lation of carbachol, CCK-8, ionomycin, TPA, and forskolin stimulation ofpepsinogen secretion 
Secretagogue Secretagogue concentration (log M) 
0 -10 -9  -8  -7  -6  -5  2× -5  -4  -3  
Carbachol 159 + 12 . . . .  217 + 52 453 + 82 a - 634 + 121 0 728 + 47 0 
CCK-8 256+71 - - - 339+70 739_+ 112 a 847_+ 189° 1220+ 166° _ _ 
Ionomycin 354 _ 92 - - - 334_+ 29 2714-t- 187 0 3701 _+ 294 b 4549 + 542 b _ _ 
TPA 94+15 210+39 1035_+85 4192_511 ° 5722-t-636 ° . . . . .  
Forskolin 146 + 25 - - - 234 -+ 18 435 _+ 58 739 _+ 48 0 _ 873 + 136 0 _ 
The chief cell monolayers were cultured at 37 ° C in the absence or presence ofseveral concentrations of carbachol, CCK-8, ionomycin, TPA, and forskolin 
for 30 min. Pepsinogen secreted into the culture medium was measured by an enzyme immunoassay forguinea pig pepsinogen. Pepsinogen secretion was 
expressed asnanograms ofpepsinogen (means + S.E.M.) per 5 - 105 chief ceils for 6 determinations. 
a p < 0.05. b p < 0.01, compared to cells incubated without he secretagogue. 
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Table 2 
Time course of basal and stimulated pepsinogen secretion by carbachol, 
CCK-8, ionomycin, TPA, and forskolin 
Secretagogue Pepsinogen secretion 
0 min 30 min 60 rain 90 min 120 min 
Basal 120+ 10 2305:38 227___46 371+80 5915:91 
Carbachol 89+11 734+121 764+112 813+94 9675:137 
CCK-8 106+9 7025:86, 884+133 9535:175 976+133 
Ionomycin 1495:20 35595:26,9 3948+450 4306+363 46595:432 
TPA 142+12 4192+511 56695:343 6523+628 65575:637 
Forskolin 104+ 10 739+48 10805:79 763+64 10065:130 
The chief cell monolayers were cultured at 37°C in the absence or 
presence of 10 -4 M carbachol, 10 -5 M CCK-8, 10 -6  M ionomycin, 
10 -s M TPA, and 10 -5 M forskolin for 0-120 min. Pepsinogen secreted 
into the culture medium was measured by an enzyme immunoassay for 
guinea pig pepsinogen. Pepsinogen secretion was expressed as nanograms 
of pepsinogen (means+ S.E.M.) per 5.105 chief cells for 6 determina- 
tions, but basal secretion for 17 determinations. 
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Fig. 1. Effects of KN-62 on pep,;inogen secretion induced by carbachol 
(A), CCK-8 (B), and ionomycin (C). Cells were preincubated with KN-62 
for 30 min before incubation with 10 -4 M carbachol (n = 6), 10 -5 M 
CCK-8  (n  = 6), or 10 -6  M ionomycin (n = 5) for 30 rain (solid bars). 
Basal secretion is shown by open bars. Values are means-I-S.E.M. 
* P < 0.05, * * P < 0.01, as compared to cells incubated with respective 
secretagogues but preincubated in the absence of KN-62. 
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Fig. 2. Effects of KN-04 on pepsinogen secretion induced by carbachol 
(A), CCK-8 (B), and ionomycin (C). Cells were preincubated with KN-04 
for 30 min before incubation with 10 -4 M carbachol (n = 5), 10 -5 M 
CCK-8  (n  = 5), or 10 -6  M ionomycin (n = 5) for 30 min (solid bars). 
Basal secretion is shown by open bars. Values are means-I-S.E.M. 
coversl ip with a si l icon rubber  wall  (F lexiperm-Disc;  Her- 
aeus Biotechnology,  Hanau,  Germany) ,  after which the 
culture med ium was replaced with a solut ion conta in ing 
130 mM NaCI, 5.4 mM KCI, 1.8 mM CaC12, 0.8 mM 
MgCI  2, 5.5 mM glucose, and 20 mM Hepes (pH 7.4). The 
cells were loaded with 5 /xM fura-2 acetoxymethylester  
(Doj in Laborator ies,  Kumamoto ,  Japan)  in the same solu- 
t ion for 60 min  under  5% CO 2 in air at 37°C.  The 
coversl ip was mounted  on an inverted epi f luorescence 
microscope (model  IMT-2;  Olympus,  Tokyo, Japan) with a 
xenon lamp and interference fi lters of  340 and 360 nm. Six 
cells were chosen at random in each preparat ion,  and then 
i l luminated by excitat ion beams of  340 and 360 nm, 
alternately (FC-200 type Ca 2 ÷ analyzer;  Mitsubishi ,  Tokyo,  
Japan). Rat ios of  emitted f luorescence ( f luorescence inten- 
sity under  340 nm divided by that under  360 nm)  give the 
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absolute [Ca 2+ ]i after calibration. This system can monitor 
the changes in [Ca 2÷ ]i in single cells [17-19]. 
The effects of KN-62 on the [Ca 2 ÷ ]i induced by carba- 
chol, CCK-8, and ionomycin were determined for 6 min in 
single chief cells. 
2.4. Immunohistochemical studies 
For immunohistochemistry, chief cells were cultured for 
48 h on 4-well chamber slides (Nunc, Naperville, IL) 
coated with collagen type I. The cells were incubated in 
the absence or presence of carbachol, ionomycin, TPA, or 
forskolin for 30 min at 37°C in the culture medium, and 
then fixed overnight at 4 ° C with 4% (w/v)  paraformal- 
dehyde in phosphate-buffered saline containing 0.9 mM 
CaC12 and 0.5 mM MgC12. The cells were transferred 
sequentially to a permeative solution [0.1% (v/v)  Triton 
X-100 in phosphate-buffered saline] for 15 min at room 
temperature, to primary antibody (IgG) for the Thr-286-au- 
tophosphorylated c~subunit of CaMK II [1:100 dilution 
with phosphate-buffered saline containing 10% (v/v)  fetal 
bovine serum] (given by T. Suzuki, [15]) or antibody 
preabsorbed with antigen (60/zg/ml) (peptide Y-66, which 
has the same sequence as the Thr-286-autophosphorylated 
a subunit of CaMK II [15]) (given by T. Suzuki, [15]) for 
60 min at 4°C, and finally to secondary antibody [1:100 
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Fig. 3. Effects of KN-62 on pepsinogen secretion induced by TPA (A) 
and forskolin (B). Cells were preincubated with KN-62 for 30 min before 
incubation with 10 -8 M TPA (n = 5) or 10 -5 M forskolin (n = 6) for 30 
min (solid bars). Basal secretion is shown by open bars. Values are 
means + S.E.M. 
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Fig. 4. Typical effects of KN-62 on the increase in [Ca 2÷ ]~ induced by 
10 -4 M carbachol (A), 10 -5 M CCK-8 (B), and 10 -5 M ionomycin (C). 
Cells were preincubated for 30 min with 10 -6 M KN-62 for the 
experiments with carbachol and CCK-8, and with 10 -5 M KN-62 for the 
ionomycin experiments. 
dilution with phosphate-buffered saline containing 10% 
(v/v)  fetal bovine serum] (Cappel, Durham, NC) for 60 
min at 4 ° C. The all immunohistochemical studies were 
replicated three times. 
2.5. Statistical analysis 
Unless otherwise indicated, results are expressed as 
means + S.E.M. Multiple comparisons of data from all 
experiments were performed with the Duncan test. Proba- 
bility (P)  values of < 0.05 were considered significant. 
3. Results 
3.1. Effects of KN-62 and KN-04 on pepsinogen secretion 
induced by secretagogues that stimulate the Ca z + messen- 
ger pathway 
Preincubation with KN-62 at 10 -8, 10 -7,  and 10 -6 M 
for 30 min significantly reduced the secretion induced by 
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10 -4 M carbachol (36, 59, and 61% reduction), 10 -5 M 
CCK-8 (37, 45, and 52% reduction), and 10 -6  M iono- 
mycin (31, 38, and 48% reduction) in a dose-dependent 
manner (Fig. 1). However, preincubation with the inactive 
analog of KN-62, KN-04, for 30 min did not affect 
C 
pepsinogen secretion induced by the same secretagogues 
(Fig. 2). These effects of KN-04 confirmed the specificity 
of the inhibitory action of KN-62 on pepsinogen secretion 
induced by secretagogues that stimulate the Ca 2÷ second 
messenger pathway. 
D 
F 
Fig. 5. Chief cells stained with antibody for the Thr-286-autophosphorylated  subunit of CaMK II without (B) or with 30 min stimulation by 10 -6 M 
ionomycin (C), 10 -4  M carbachol (D), 10 -8 M TPA (E), and 10 -5 M forskolin (F). As a negative control, the cells were stained with antibody that had 
been preabsorbed with peptide Y-66 antigen (A). The calibration bar in (F) indicates 10 /xm. 
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3.2. Effects of KN-62 on pepsinogen secretion induced by 
secretagogues that stimulate protein kinase C or the cAMP 
messenger pathway 
Preincubation with KN-62 (10 -8, 10 -7, and 10 -6 M) 
for 30 min did not affect the secretion of pepsinogen 
induced by 10 -8 M TPA or 10 -5 M forskolin (Fig. 3). 
3.3. Effects of KN-62 on the increase in [Ca 2 + ]i induced 
by carbachol, CCK-8, and ionomycin 
A large increase in [Ca 2+ ]i was observed after stimula- 
tion of the cultured cells with 10 -4 M carbachol, 10 -5 M 
CCK-8, and 10 -5 M ionomycin (233 + 11%, 187 + 4%, 
and 230 + 19% increase, respectively, from 6 cells). Iono- 
mycin at a concentration of 10 -6 M did not elevate 
[CaZ÷]i; therefore, 10 -5 M ionomycin was used in this 
study. Preincubation of the cells with KN-62 for 30 min 
did not affect the increase in [Ca 2÷ ]i induced by the same 
concentrations of carbachol, CCK-8, and ionomycin (231 
_ 23%, 197 + 17% and 225 + 22% increase, respectively, 
from 6 cells). The concentration of KN-62 was 10 -6 M 
for stimulation with carbachol or CCK-8 and 10 -5 M for 
that with ionomycin. Representative [Ca 2+ ]i traces reveal- 
ing the effects of KN-62 are shown in Fig. 4. 
3.4. Immunohistochemical studies on the autophosphoryla- 
tion of CaMK H 
The intramolecular utophosphorylation of CaMK II in 
chief cells was evaluated by immunohistochemistry with 
the antibody for the Thr-286-autophosphorylated  sub- 
unit of CaMK II (peptide Y-66). The cytoplasm and 
nucleus of untreated chief cells showed slight staining with 
the antibody(Fig. 5B), but did not stain with the antibody 
preabsorbed with peptide Y-66 antigen (Fig. 5A). Much 
stronger staining was observed in the cells treated with 
10 -6 M ionomycin (Fig. 5C) or 10 -4 M carbachol (Fig. 
5D), especially in the cytoplasm; however, only slight 
staining was observed in the cells treated with 10 -8 M 
TPA (Fig. 5E) or 10 -s M forskolin (Fig. 5F). No staining 
with antibody that had been preabsorbed with peptide 
Y-66 was seen in the cells treated with the same concentra- 
tions of ionomycin, carbachol, TPA, or forskolin (data not 
shown). 
3.5. Cell viability 
Cell viability was determined by trypan blue exclusion 
after pepsinogen secretion studies. Viability of the cells 
that had not been exposed to drugs was 97.0 + 1.7% 
(mean + S.D.) for 33 separate wells. Cell damage, corre- 
sponding to a cell viability 2 S.D. below that of untreated 
cells, was not detected in any experiment (data not shown). 
4. Discussion 
CaMK II is distributed widely in many mammalian 
tissues [6,20-22] -the brain, islets of the pancreas, keletal 
muscle, uriniferus tubules of the kidney, pituitary gland, 
and gastric glands [21]. Messenger RNA for CaMK II has 
been seen in the small intestine [22], indicating that CaMK 
II might also function in the alimentary tract. Recently, a 
specific inhibitor of CaMK II, KN-62, was synthesized 
[10]. KN-62 affects the interaction between 
Ca2+/calmodulin complex and inactivated CaMK I1 by 
directly binding to the calmodulin binding site of CaMK II 
but does not affect the activity of already autophosphory- 
lated (activated) CaMK II [10]. KN-62 inhibits more than 
80% of the CaMK II activity at a concentration of 10 -6 
M; however, the activities of the cAMP-dependent protein 
kinase, myosin light-chain kinase, and protein kinase C, 
are affected only slightly in the presence of 10 -4.5 M 
CaMK II (cAMP-dependent protein kinase, 22%; myosin 
light-chain kinase, 12%; protein kinase C, 12% of in- 
hibitory rate) [10]. Because the inhibition of KN-62 against 
CaMK II was more significant han against the other 
protein kinase, KN-62 seems to be a selective and potent 
inhibitor of CaMK II. With the use of KN-62, an important 
role was established for CaMK II in acid secretion. KN-62 
inhibits carbachol-induced acid secretion without alternat- 
ing [Ca2+]i in parietal cells [7]. However, the role of 
CaMK II has not been investigated in chief cells. We 
therefore tested the involvement of CaMK II in the secre- 
tion of pepsinogen from chief cells. 
KN-62 specifically inhibited pepsinogen secretion in- 
duced by secretagogues that stimulate the Ca 2+ second 
messenger pathway, such as carbachol, CCK-8, and iono- 
mycin, in a dose-dependent manner. These results were 
confirmed by using KN-04; this inactive analog of KN-62 
did not affect he secretion induced by such secretagogues, 
suggesting that the inhibitory effects of KN-62 on pepsino- 
gen secretion did not seem to be non-specific. By contrast, 
KN-62 did not affect the pepsinogen secretion induced by 
TPA (a stimulator of protein kinase C) or forskolin (an 
activator of the cAMP second messenger pathway), neither 
of which affect [Ca2+] i [23]. In addition, KN-62 did not 
affect he increase in [Ca 2÷ ]i induced by carbachol, CCK-8, 
and ionomycin. KN-62 has been reported to inhibit insulin 
secretion from HIT-T15 cells by blocking Ca 2+ channels 
of cell membrane because KN-62 had no effect on the 
secretion from permeabilized cells but inhibited the sus- 
tained rises of  [Ca2+]i , which are due to Ca 2+ influx via 
Ca 2+ channels [24]. However, KN-62 did not affect the 
sustained rises of [Ca 2÷ ]i induced by carbachol and CCK-8 
in our studies (Fig. 4), impling that KN-62 may not act on 
Ca 2÷ channels of chief cell membrane. These findings 
indicate that CaMK II partly participates in Ca2÷-depen - 
dent secretion triggered by the elevation of [Ca 2÷ ]i and is 
not involved in the secretion related to protein kinase C or 
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the cAMP second messenger pathway in chief cells. We 
previously reported that myosin light-chain kinase was 
also involved in pepsinogen secretion independent of pro- 
tein kinase C and the cAMP second messenger pathway 
[11], indicating that the mechanism of activating CaMK II 
may be similar to that of myosin light-chain kinase in chief 
cells. 
Triggering of intramolecular autophosphorylation f 
CaMK II by Ca 2÷ could prolong the effect of a transient 
increase in [Ca 2÷ ]i and allow CaMK II to phosphorylate 
substrate proteins even when [Ca2+]i returns to the basal 
concentration [5,6]. In this study, the autophosphorylation 
of CaMK II in chief cells was demonstrated by using 
antibody that specifically recognizes autophosphorylated 
CaMK II. The cytoplasm and nucleus of untreated chief 
cells contained small ;amounts of autophosphorylated 
CaMK II. However, much more autophosphorylated CaMK 
II was observed in ionomycin-or carbachol-treated cells 
compared to the cells treated with TPA or forskolin. These 
data suggest hat the autophosphorylation of CaMK II is 
caused by the ionomycin-or carbachol-induced increase in 
[ Ca2+ ]i, and that the autophosphorylated CaMK II proba- 
bly stimulates pepsinogen secretion after [Ca2+]i has re- 
turned to the basal concentration. 
In conclusion, these studies imply that CaMK II and the 
autophosphorylation of this kinase may be involved in the 
Ca2÷-dependent pepsinogen secretion from chief cells. 
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